Trial reportObesity surgery2026
Effect of Roux-en-Y Gastric Bypass Surgery and Restricted Diet on Endothelial Progenitor Cells in Egyptian Subjects with Morbid Obesity.
Trial report in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMorbid obesity is a multifactorial disease that impacts cardiovascular system. Endothelial progenitor cells (EPCs), which play a critical role in endothelial repair and angiogenesis, are dysregulated in obesity. The comparative effects of bariatric surgery and dietary intervention on EPCs and oxidative stress remain incompletely understood. This study aimed to evaluate changes in EPC concentrations, oxidative stress levels, antioxidant activity, lipid profile, and insulin sensitivity in women with morbid obesity undergoing Roux-en-Y gastric bypass (RYGB) versus diet restriction.
methodsSeventy-two female subjects with obesity (BMI > 30 kg/m²) were randomly divided into two groups (n = 36 each): one underwent RYGB surgery, and the other followed a restricted diet. EPCs were measured by flow cytometry, while oxidative stress markers and antioxidant enzymes were determined using an enzymatic colorimetric method. Insulin levels were measured by the ELISA technique, and the spectrophotometric method was used for the determination of fasting blood glucose and lipid profile.
resultsBoth interventions significantly reduced BMI, lipid levels, and oxidative stress, in addition to improving antioxidant capacity and insulin sensitivity. However, the RYGB procedure induced greater improvements across all metabolic and oxidative parameters. EPC declined significantly post-intervention, more markedly in the RYGB group (50%) than the diet group (42.85%). This decrease likely reflects a reduction in endothelial injury and hypoxic signaling.
conclusionRYGB surgery is more effective than diet restriction in reducing oxidative stress, improving antioxidant defense, and restoring EPCs homeostasis. These benefits may reflect reduced vascular stress and improved endothelial function, supporting RYGB surgery as a potent metabolic intervention for morbid obesity.
Indexed as
Identifiers
42467325What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.